Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate ProgramChristine Robin, Catherine Cordonnier, Nathalie Bénard et al.|Biology of Blood and Marrow Transplantation|2020Cited by 77
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirusRaphaële Germi, Patrice Morand, Anne Thiébaut et al.|Antiviral Research|2013Cited by 71